Sickle Cell Disease Treatment Centers Act of 2022
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Sep 15, 2022)
Sickle Cell Disease Treatment Centers Act of 2022
This bill directs the Department of Health and Human Services to award grants for establishing sickle cell disease treatment centers that operate using a hub-and-spoke framework to provide integrated, longitudinal health care for patients with the disease and individuals with sickle cell trait. Grant recipients must be networks comprised of (1) a hospital, clinic, or university health center; (2) at least one federally qualified health center or other health care organization that incorporates community health workers into the care team; and (3) at least one community-based organization.
Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.
What just happenedSep 16, 2022
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseSep 15, 2022
- Sep 16, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 15, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Sep 15, 2022IntroReferralIntro-H
Introduced in House
- Sep 15, 2022IntroReferral1000
Introduced in House